Alport Syndrome Clinical Trials Alport Syndrome RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Study of Weekly RG-012 Injections in Patients With Alport Syndrome
Condition:   Alport Syndrome Interventions:   Drug: RG-012;   Drug: Placebo Sponsor:   Regulus Therapeutics Inc. Not yet recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2016 Category: Research Source Type: clinical trials